Araujo Zaida, de Waard Jacobus H, Camargo Milena, Lopez-Ramos Juan Ernesto, de Larrea Carlos Fernández, Vanegas Magnolia, Patarroyo Manuel A
Laboratorio de Inmunología de Enfermedades Infecciosas, Instituto de Biomedicina "Dr. Jacinto Convit", Universidad Central de Venezuela, San José, Apartado 4043, Caracas, 1010A Caracas D.C Venezuela.
Laboratorio de Tuberculosis, Instituto de Biomedicina "Dr. Jacinto Convit", Universidad Central de Venezuela, San José, Apartado 4043, Caracas, 1010A Caracas D.C Venezuela.
Int J Pept Res Ther. 2022;28(3):98. doi: 10.1007/s10989-022-10392-3. Epub 2022 May 3.
Diagnosis and treatment of active tuberculosis (ATB) as well as latent tuberculosis infection (LTBI) are required for effective tuberculosis (TB) control, especially in TB endemic area. The usefulness of conventional tests to distinguish between ATB and LTBI has remained challenging. The present study was aimed to demonstrate the usefulness of the serological response to synthetic peptides from () antigens for discrimination between ATB and LTBI in Warao Amerindians. erum IgG antibody levels were measured by the indirect ELISA assay using 22 designed and synthesized peptides derived from immunogenic ESAT-6 and Ag85A proteins. A total of 211 adult Warao Amerindians were included; cases with active TB (ATB, n = 75), latent TB infection (LTBI, n = 85) and non-infected (NI, n = 51). The approach's diagnostic information was compared using receiver operating characteristic (ROC) curves. For ATB diagnostic performance between ATB and NI; ESAT-6; P-12037 had 100% of sensitivity (AUC = 0.812; 0.733 to 0.891 95% CI); and Ag85A; P-10997 had 100% of specificity (AUC = 0.691; 0.597 to 0.785 95% CI); and ATB and LTBI; Ag85A; P-29878 had 100% of sensitivity (AUC = 0.741; 0.666-0.817 95% CI), and P-29879 had 99% of specificity (AUC = 0.679; 0.593-0.765 95% CI). While that ESAT-6 P-12037 also allowed differentiation between LTBI and NI or healthy ones. It had 98.8% of sensitivity and 98.0% of specificity (AUC = 0.640; 0.545-0.735 95% CI). The potential of combination-antigen immunoassays with peptides could discriminate between Warao Amerindians with ATB, LTBI and NI. Further validation of this approach could lead to developing a complementary tool for rapid diagnosis of TB infections.
有效控制结核病(TB),尤其是在结核病流行地区,需要对活动性结核病(ATB)和潜伏性结核感染(LTBI)进行诊断和治疗。传统检测方法用于区分ATB和LTBI一直具有挑战性。本研究旨在证明针对()抗原合成肽的血清学反应在区分瓦劳美洲印第安人中的ATB和LTBI方面的有效性。使用从免疫原性ESAT-6和Ag85A蛋白衍生的22种设计和合成肽,通过间接ELISA测定法测量血清IgG抗体水平。总共纳入了211名成年瓦劳美洲印第安人;活动性结核病患者(ATB,n = 75)、潜伏性结核感染患者(LTBI,n = 85)和未感染患者(NI,n = 51)。使用受试者工作特征(ROC)曲线比较该方法的诊断信息。对于ATB与NI之间的诊断性能;ESAT-6;P-12037的敏感性为100%(AUC = 0.812;0.733至0.891,95%CI);Ag85A;P-10997的特异性为100%(AUC = 0.691;0.597至0.785,95%CI);对于ATB与LTBI;Ag85A;P-29878的敏感性为100%(AUC = 0.741;0.666 - 0.817,95%CI),P-29879的特异性为99%(AUC = 0.679;0.593 - 0.765,95%CI)。而ESAT-6 P-12037也能够区分LTBI与NI或健康个体。其敏感性为98.8%,特异性为98.0%(AUC = 0.640;0.545 - 0.735,95%CI)。肽联合抗原免疫测定法有潜力区分患有ATB、LTBI和NI的瓦劳美洲印第安人。对该方法的进一步验证可能会开发出一种用于快速诊断结核感染的补充工具。